1057 related articles for article (PubMed ID: 15935238)
61. Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.
Zhu B; Tunis SL; Zhao Z; Baker RW; Lage MJ; Shi L; Tohen M
Curr Med Res Opin; 2005 Apr; 21(4):555-64. PubMed ID: 15899104
[TBL] [Abstract][Full Text] [Related]
62. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
Suppes T; Vieta E; Gustafsson U; Ekholm B
Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
[TBL] [Abstract][Full Text] [Related]
63. Predictors of treatment response in bipolar disorders: evidence from clinical and brain imaging studies.
Ketter TA; Wang PW
J Clin Psychiatry; 2002; 63 Suppl 3():21-5. PubMed ID: 11908918
[TBL] [Abstract][Full Text] [Related]
64. Lamotrigine combined with divalproex or lithium for bipolar disorder: a case series.
Redmond JR; Jamison KL; Bowden CL
CNS Spectr; 2006 Dec; 11(12):915-8. PubMed ID: 17146405
[TBL] [Abstract][Full Text] [Related]
65. Divalproex sodium vs. valproic acid: drug utilization patterns, persistence rates and predictors of hospitalization among VA patients diagnosed with bipolar disorder.
Iqbal SU; Cunningham F; Lee A; Wang S; Hamed A; Miller DR; Ren X; Kazis L
J Clin Pharm Ther; 2007 Dec; 32(6):625-32. PubMed ID: 18021341
[TBL] [Abstract][Full Text] [Related]
66. Report on efficacy of treatments for bipolar disorder.
Gelenberg AJ; Hopkins HS
Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977
[TBL] [Abstract][Full Text] [Related]
67. Cost-effectiveness of improving primary care treatment of late-life depression.
Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
[TBL] [Abstract][Full Text] [Related]
68. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified.
Greil W; Kleindienst N
Int Clin Psychopharmacol; 1999 Sep; 14(5):283-5. PubMed ID: 10529071
[TBL] [Abstract][Full Text] [Related]
69. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
Evins AE
J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
[TBL] [Abstract][Full Text] [Related]
70. [Valproate in the treatment of bipolar disorder].
Rzewuska M
Psychiatr Pol; 2002; 36(2):239-57. PubMed ID: 12043042
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
[TBL] [Abstract][Full Text] [Related]
72. Non-lithium treatment for bipolar disorder.
Post RM
J Clin Psychiatry; 1990 Aug; 51 Suppl():9-16; discussion 17-9. PubMed ID: 2116406
[TBL] [Abstract][Full Text] [Related]
73. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
74. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
[TBL] [Abstract][Full Text] [Related]
75. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
[TBL] [Abstract][Full Text] [Related]
76. A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
McElroy SL; Keck PE; Stanton SP; Tugrul KC; Bennett JA; Strakowski SM
J Clin Psychiatry; 1996 Apr; 57(4):142-6. PubMed ID: 8601548
[TBL] [Abstract][Full Text] [Related]
77. [Risk of inducing resistance upon stopping and restarting lithium after long-term usage].
Oostervink F; Nolen WA; Hoenderboom AC; Kupka RW
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):401-4. PubMed ID: 10719540
[TBL] [Abstract][Full Text] [Related]
78. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
Reischies FM; Hartikainen J; Berghöfer AM
Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
[TBL] [Abstract][Full Text] [Related]
79. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
[TBL] [Abstract][Full Text] [Related]
80. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E; Angst J; Reed C; Bertsch J; Haro JM;
J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
